novavax - Search News

News

Novavax, FDA and COVID-19 vaccine

Reuters on MSN · 23h

As FDA delays Novavax' COVID vaccine approval, patients fight back

By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert F.

Associated Press News on MSN · 1d

Novavax says its COVID-19 shot is on track for full FDA approval after delay

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug Administration.

BioSpace · 23h

After Missed Decision Deadline, Novavax Says COVID-19 Shot ‘Approvable’

The FDA is asking Novavax for a non-mandatory postmarketing commitment to produce additional clinical data for its investigational COVID-19 vaccine.

14h

Novavax Inc. stock underperforms Thursday when compared to competitors

Shares of Novavax Inc. NVAX slid 5.35% to $7.07 Thursday, on what proved to be an all-around favorable trading session for ...

Novavax Booster's Fate in Limbo: FDA Considers Approval Amid Controversy

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

Tariff questions swirl around pharma earnings

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Zacks.com on MSN1d

Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

1d

Novavax has improved clarity on path forward for Nuvaxovid, says BofA

BofA notes that Novavax (NVAX) shares are up 21% after announcing the company has received communication from the FDA for a post marketing ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results